RE: Shorters5 Nov 2020 22:31
The share price at this level has factored in a dilution of some sorts.......the share purchases throw this assumption out of the window..... a fair valuation imho at this point in time is around £1.80 to £2.00.....with a recovering market and a vaccine then a value of around £500M or £3.000 a share imho